Olmesartan Medoxomil 40 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Olmesartan Medoxomil 40 mg, covering 2021-07-28 to 2021-07-28. Get the full timeline:
Most recent: Clinical Trial Update: Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension [Phase 3]